Company Filing History:
3 out of 1,746 
1 out of 780 
1 out of 1,008 
Years Active: 2007-2010
Title: Exploring the Innovations of Stephen N Thibodeau
Introduction
Stephen N Thibodeau is an accomplished inventor based in Rochester, Minnesota, recognized for his contributions to the field of genetic research and diagnostics. With a total of three patents to his name, Thibodeau's innovations focus on methods that enhance patient care and understanding of genetic markers.
Latest Patents
Thibodeau's latest patents include groundbreaking work on the SULT1A1 gene. The first patent describes methods for determining the sulfonator status of a patient and for calculating appropriate drug dosages based on the copy number of the SULT1A1 gene. This innovation has significant implications for personalized medicine. The second patent relates to a method for detecting a differentially expressed sequence, which introduces novel human genes, their corresponding proteins, and relevant variants. Additionally, this invention includes diagnostic assays and therapeutic agents linked to the genes and proteins, particularly in relation to tumor cells and colon cancer tissue.
Career Highlights
Throughout his career, Stephen N Thibodeau has made a notable impact while working at prestigious organizations such as the Mayo Foundation for Medical Education and Research and Bayer Healthcare LLC. His research has contributed significantly to advancements in medical diagnostics and treatment strategies.
Collaborations
In his professional journey, Thibodeau has collaborated with esteemed colleagues, including Jon H Astle and Christopher C Burgess. These partnerships have resulted in fruitful research outcomes and innovations that have advanced the understanding of genetic factors in health and disease.
Conclusion
Stephen N Thibodeau is a notable figure in the realm of genetic research and innovation. His patents underline his commitment to improving patient outcomes through advanced medical technologies. As Thibodeau continues his work, the scientific community looks forward to further innovations that could reshape the future of diagnostics and therapeutic approaches.